Description
AdTab is a small, tasty chewable tablet for dogs that effectively fights fleas and ticks, providing protection for a whole month.
AdTab is a small, tasty chewable tablet for dogs with a meaty flavor that effectively fights fleas and ticks. It works quickly, after just two hours, and provides protection for a whole month. Safe and effective, AdTab has been approved by over 99% of dogs in studies, so you can be sure you are taking proper care of your pet.
This medication is suitable for puppies and dogs over 8 weeks of age and weighing over 1.3 kg. Tested for safety, AdTab did not show any interactions with other drugs often used in dogs in clinical trials.
AdTab contains lotilaner, which causes excessive stimulation of the nervous system of fleas and ticks, resulting in their death in a short time. Kills fleas and ticks on a dog or cat, affecting only fleas and ticks. The product has been tested for safety, and no interactions of the active substance with other drugs commonly used in animals were observed in clinical trials.
AdTab is a quick and convenient over-the-counter solution.
How does AdTab for dogs work?
Extensive research has shown that the active substance used is highly effective and well tolerated by dogs at the recommended doses. The active substance contained in the AdTab product causes excessive stimulation of the nervous system of fleas and ticks, resulting in their death in a short time. The tablet kills fleas on the dog before administration of the product within 6 hours and ticks on the dog before administration of the product within 8 hours. It only affects fleas and ticks, not dogs or humans, and works for a whole month.
How to administer AdTab tablets:
- Choose the AdTab product appropriate to your dog's height and weight
- Remove the tablet from the package
- Place the tablet in your dog's food or let your dog take it from your hand
- For full effectiveness, make sure you administer the tablet while your dog is feeding or within 30 minutes of the last feeding
Contraindications
Do not use in cases of hypersensitivity to the active substance or to any substance auxiliary.
Special warnings
Parasites must start feeding on the host to come into contact with lotilaner, therefore the risk of diseases transmitted by these parasites cannot be completely excluded. The possibility that other animals living in the same household may be a source of re-infestation with fleas should be considered and should be treated with an appropriate product if necessary. All stages of flea development can live in the dog's bedding and in places where the dog regularly rests, such as carpets and furniture upholstery. In the event of a massive flea infestation and at the beginning of the control process, appropriate environmental products should be applied to these areas and the areas should then be vacuumed regularly.
Special precautions for safe use in target animal species:
All safety and efficacy data obtained from dogs and puppies aged 8 weeks and over and weighing 1.3 kg and over. Due to the lack of data available, consult your veterinarian before treating puppies younger than 8 weeks or dogs weighing less than 1.3 kg.
Special precautions for persons administering the veterinary medicinal product to animals:
Wash your hands after handling the product. If accidentally swallowed, seek medical advice immediately and show the package leaflet or packaging to the physician.
Special environmental precautions:
Not applicable.
Adverse reactions
Target animal species: dogs
Very rare (< 1 animal/10,000 animals treated, including isolated reports): diarrhea, vomiting, loss of appetite, lethargy; Ataxia, convulsions, tremor
The reporting of adverse reactions is important to enable continuous monitoring of the safety of the veterinary medicinal product. Reports should preferably be sent via your veterinarian to the national competent authority or to the Marketing Authorization Holder or via the national reporting system. See also the "Contact details" section in the leaflet.
Use during pregnancy, lactation or lay
Pregnancy and lactation - laboratory studies in rats have not shown any evidence of teratogenic or teratogenic effects any side effect affecting the reproductive capacity of males and females. Please consult your veterinarian before treating pregnant or lactating animals. Fertility - consult your veterinarian before treating dogs intended for breeding.
Interactions with other medicinal products and other types of interactions
Unknown. No interactions of lotilaner with routinely used veterinary medicinal products have been observed in clinical trials.
Symptoms of overdose (and emergency procedures and antidotes, where appropriate):
No adverse reactions have been observed in puppies aged 8-9 weeks and weighing 1.3-3.6 kg, after eight oral administrations (at one-month intervals) with doses up to five times higher than the highest recommended dose (43 mg, 129 mg and 215 mg lotilaner/kg body weight).
Specific restrictions on use and special conditions of use: (including restrictions on the use of antimicrobial and antiparasitic veterinary medicinal products to reduce the risk of development of resistance): not applicable.
Withdrawal periods:
Not applicable.
